Search Result()

• Privacy Policy

  This privacy notice for Sannova Analytical, LLC (“We,” “Us,” or “Our”), describes how and why we might collect, store, use, and/or share (“Process”) your information when you use our services (“Services”), such as when you: Visit our website at sannova.net...

  

• White Paper:
  Whitepaper: Mastering HRMS for Preclinical Toxicology in Diverse Matrices

  Unlock the highest level of confidence in your preclinical toxicology studies by harnessing the capabilities of High-Resolution Mass Spectrometry (HRMS). While traditional methods lack the sensitivity needed to distinguish subtle differences in mass-to-charge ratios (m/z) between ions, particularly on low-resolution...

  

• White Paper:
  eBook: Extractables and Leachables, Regulatory Trends & Future Prospects

  In the ever-evolving landscape of pharmaceuticals, the scrutiny surrounding extractables and leachables has become increasingly pivotal. As regulatory frameworks continually adapt to advancements in technology and scientific understanding, professionals in the pharmaceutical industry find themselves at the intersection of innovation...

  

• White Paper:
  Whitepaper: High Resolution Methods for Clinical Biomarker Validation

  Discover how high-resolution biomarker assays such as Meso Scale Discovery (MSD) and advanced Mass Spectrometry (MS) go beyond the limitations of traditional ELISA assays. Gain comparative insights into the superiority of high-resolution methods, and how they overcome central challenges in...

  

• White Paper:
  Addressing Bioanalytical Method Development Challenges from Preclinical to Clinical Trials

  At Sannova, we recognize the intricate and often non-linear nature of R&D and drug development, standing ready to navigate the challenges alongside our clients. One such journey involved a client developing a nanoparticle-bound immunosuppressant. They started with a rat study...

  

• White Paper:
  Videobite: Contract Pharma Sits Down with Jason Apter of Sannova Analytical

  Jason Apter discusses the role CROs play in the drug development process, the role of AI, and strategies to accelerate drug development.

  

• Article:
  Enhancing Regulatory Compliance with E&L Analysis of Extensive Packaging Components

  The sponsor, a pharmaceutical solutions provider, embarked on the introduction of a groundbreaking oral solution product comprising two crucial components. T he sponsor decided to conduct an extensive extractable and leachable study on the packaging components to get ahead of...

  

• Article:
  A Comprehensive Extractables & Leachables Study for the Fentanyl Transdermal System

  Our client, a leading pharmaceutical company, sought a comprehensive assessment of the Extractables and Leachables (E&L) profile associated with their Fentanyl Transdermal System packaging. With a commitment to ensuring product safety and compliance, they aimed to understand the potential impact...

  

• White Paper:
  Managing Customer Experiences – Blending capability with customer needs.

  In the dynamic world of life sciences, mastering customer experience (CX) is paramount. Discover how one can tackle unique challenges and boost revenue through effective CX. Join us for this insightful conversation on leadership, innovation, and prioritizing CX.

  

• White Paper:
  Get a sneak peek into Sannova Analytical’s digital transformation that will change the CRO landscape

  The new Sannova: the big science, boutique CRO redefining the future of bioanalytical and analytical services. We embarked on a quest for excellence, committed to crafting an unrivaled customer experience hallmarked by quality, speed, and flexibility. The world of pharma...